New Zealand - English - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - acitretin 10mg;   - capsule - 10 mg - active: acitretin 10mg   excipient: gelatin   iron oxide black iron oxide red iron oxide yellow maltodextrin microcrystalline cellulose sodium ascorbate titanium dioxide   - neotigason is indicated for the following indications: · severe psoriasis · disorders of keratinization, such as ichthyotic disorders, palmoplantar keratoderma, darier's disease and lichen planus. · other dermatoses responsive to etretinate.

Israel - English - Ministry of Health

abic marketing ltd, israel - acitretin - capsules - acitretin 10 mg - acitretin - severe disorders of keratinization such as erythrodermic psoriasis local or generalized pustular psoriasis congenital ichthyosis pityriasis rubra pilaris darier's disease.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

teva uk ltd - acitretin - oral capsule - 10mg

Ireland - English - HPRA (Health Products Regulatory Authority)

teva b.v. - acitretin - capsule, hard - retinoids for treatment of psoriasis; acitretin

Ireland - English - HPRA (Health Products Regulatory Authority)

actavis group ptc ehf - acitretin - capsule, hard - 10 milligram(s) - retinoids for treatment of psoriasis; acitretin

Ireland - English - HPRA (Health Products Regulatory Authority)

lexon (uk) ltd - acitretin - capsule - 10 milligram(s) - retinoids for treatment of psoriasis; acitretin

Australia - English - Department of Health (Therapeutic Goods Administration)

teva pharma australia pty ltd - acitretin, quantity: 10 mg - capsule, hard - excipient ingredients: iron oxide red; spray-dried liquid glucose; iron oxide yellow; iron oxide black; gelatin; microcrystalline cellulose; sodium ascorbate; titanium dioxide; propylene glycol; butan-1-ol; isopropyl alcohol; strong ammonia solution; ethanol; shellac; sulfuric acid - acitretin may be used for the treatment of severe intractable psoriasis in all its forms. severe forms of disorders of keratinisation such as: hyperkeratosis palmaris et plantaris; pustulosis palmaris et plantaris; ichthyosis; keratosis follicularis (darier's disease); lichen planus affecting the skin or the mucosae; pityriasis rubra pilaris.

Ireland - English - HPRA (Health Products Regulatory Authority)

pco manufacturing ltd. - acitretin - capsule - acitretin

Singapore - English - HSA (Health Sciences Authority)

teva pharmaceutical investments singapore pte. ltd. - acitretin - capsule - 10 mg - acitretin 10 mg

Australia - English - Department of Health (Therapeutic Goods Administration)

douglas pharmaceuticals australia pty ltd - acitretin, quantity: 10 mg - capsule, hard - excipient ingredients: titanium dioxide; purified water; sodium lauryl sulfate; iron oxide red; gelatin; maltodextrin; microcrystalline cellulose; sodium ascorbate; propylene glycol; butan-1-ol; isopropyl alcohol; strong ammonia solution; iron oxide black; ethanol; shellac; sulfuric acid - acitretin may be used for the treatment of:,? severe intractable psoriasis in all its forms,? severe forms of disorders of keratinisation such as,- hyperkeratosis palmaris et plantaris,- pustulosis palmaris et plantaris,- ichthyosis,- keratosis follicularis (darier's disease),- lichen planus affecting the skin or the mucosae,- pityriasis rubra pilaris